Market Closed -
Other stock markets
|
After market 04:32:13 pm | |||
20.97 USD | +18.07% | 21.04 | +0.36% |
02:47pm | COVID shots for JN.1 variant neutralize newer strains, vaccine makers say | RE |
Jun. 03 | COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+336.88% | 2.49B | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Transcript : Novavax, Inc., Q1 2024 Earnings Call, May 10, 2024